Moderna, Inc. Common Stock (MRNA) — Analysis Summary
Moderna, Inc. Common Stock (MRNA) has a market cap of $18.72B with year-over-year revenue growth of -39.9%. Net margin stands at -145.2%. The stock trades at a P/E ratio of -5.9.
Key Takeaways
- Revenue changed -39.9% year-over-year
- Net margin of -145.2%
- P/E ratio of -5.9
Compared to other companies in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector, MRNA posted revenue growth of -39.9% and trades at a P/E of -5.9.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.